Cochlear help people hear and be heard. The company empowers people to connect with others and live a full life. They help transform the way people understand and treat hearing loss. They innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes.
Seer is a medical technology company that specializes in the diagnosis and management of neurological conditions. Its technology consists of wearable devices, a cloud platform, and machine learning systems. The company is driven by a mission to empower people by delivering personalized deep clinical insights by utilizing the latest technology. Seer was founded in 2016 and is headquartered in Melbourne, Victoria.
Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Nyxoah is a health-technology company focused on the development and commercialization of innovative solutions and services to treat sleep disordered breathing conditions. Nyxoah's lead solution platform is based on the Genio® system, a validated, user-centered, next generation neurostimulation therapy for OSA, the world's most common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process. The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.
Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly activates natural hearing, delivering the broadest bandwidth available today and superior sound quality. This revolutionary, non-surgical hearing solution uses a small lens to vibrate the eardrum, replicating the natural hearing process. The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. Unlike traditional hearing aids, which are in effect tiny speakers that simply turn up the volume on air conducted sound, the Earlens Contact Hearing Solution™ is the world’s first to deliver sound directly to the eardrum.
Otologics, LLC, a medical device company, develops and manufactures amplification products that are designed to improve communication of life for individuals with hearing loss. It offers Carina, an implantable treatment option for hearing loss. The company was founded in 1996 and is headquartered in Boulder, Colorado.
Cochlear Bone Anchored Solutions
Acquisition in 2005
Cochlear Bone Anchored Solutions manufactures, and sells medical systems for hearing and facial rehabilitation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.